Correction: Mapping Evidence on the Regulations Affecting the Accessibility, Availability, and Management of Snake Antivenom Globally: A Scoping Review (Tropical Medicine and Infectious Disease, (2025), 10, 8, (228), 10.3390/tropicalmed10080228)

In the original publication [1], there was a mistake in Table 2, ‘Summary of the key findings corresponding to the emerging themes’. The original sentence with a mistake is ‘Lack of standardized treatment guidelines and commercial export policy in Africa’, which is in Column 2, Row 2. The corrected sentence is ‘Lack of commercial export policy in Africa’. The revised Table 2 is provided below. There was an error in Section 3.3.1 (Regulatory frameworks), Paragraph 6. The original sentence with a mistake is ‘The sole antivenom manufacturer in South Africa has no commercial export policy. Additionally, there are no national standardized SBE treatment guidelines [32–34].’ The corrected sentence is ‘The sole antivenom manufacturer in South Africa has no commercial export policy for public scrutiny, according to the included literature [32].’ Reference number 32 and 34 removed from the paper, so reference 33 in the original version should become 32 in the citation list at the end. Subsequent reference numbers are updated. With this correction, the order of some references has been adjusted accordingly. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.